FIELD: pharmaceuticals.
SUBSTANCE: invention relates to novel biologically active compounds, namely to peptides with neuroprotective and normalizing activity. Hexapeptide (1) of the formula Thr-Gly-Glu-Hse-His-Arg-NH2 as a neuroprotective and normalizing agent. New composition of a pharmaceutical composition based on a peptide containing hexapeptide (2.5 g/l) as active ingredient, a preservative in the form of nipagine (1.0 g/l), sodium chloride (10.0 g/l) and distilled water – the rest.
EFFECT: peptide has a high neuroprotective activity and can be used to produce a highly effective and non-toxic drug, which is used in the form of drops in the nose, and is intended for the prevention or treatment of Parkinson's disease.
2 cl, 3 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
| ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
| TREATMENT OF NEUROLOGICAL DISEASES | 2017 |
|
RU2755997C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING BURN SKIN LESIONS | 2018 |
|
RU2704621C1 |
| METHOD FOR EARLY PRECLINICAL DIAGNOSTICS OF PARKINSON'S DISEASE BY CONCENTRATION OF CATECHOLAMINES IN PATIENT'S LACRIMAL FLUID | 2019 |
|
RU2775261C2 |
| PEPTIDE DERIVATIVES - ANALOGS OF GRF OR THEIR NONTOXIC SALTS | 1990 |
|
RU2096416C1 |
| AGENT REDUCING RELATIVE CONTENT OF LOW-DIFFERENTIATED CELLS AND INCREASING RELATIVE CONTENT OF HIGH-DIFFERENTIATED CELLS IN INVASIVE MAMMARY GLAND CARCINOMA OF NON-SPECIFIC TYPE | 2022 |
|
RU2786528C1 |
| PHARMACEUTICAL COMPOSITION BASED ON ALPHA-METHYL-P-TYROSINE AND A METHOD FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | 2019 |
|
RU2719575C1 |
| AGENTS, APPLICATION WAYS AND METHODS FOR TREATING SYNUCLEOPATHY | 2016 |
|
RU2765303C2 |
| LACTOFERRIN, USED IN DIAGNOSING OR PREDICTING ALZHEIMER'S DISEASE OR DIAGNOSING PARKINSON'S DISEASE | 2016 |
|
RU2745602C2 |
